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Abstract 
Background: Extracranial metastasis of malignant meningioma to soft tissues is extremely rare and its clinical, radio-
logical and pathological features are not well-characterised.
Case presentation: We report a case of a 58 year old man who presented with a mobile mass within the left trape-
zius muscle. The patient had previously undergone surgery for a right frontal lobe high grade anaplastic meningioma. 
Histology of the soft tissue lesion showed metastatic anaplastic meningioma with clumps of pleomorphic tumour 
cells which expressed epithelial membrane antigen, cytokeratin and P63 but were negative for other epithelial and 
mesenchymal markers. A PET-CT scan revealed additional metastatic lesions in the left pleura, liver and iliac bone.
Conclusions: Metastatic malignant meningioma can very rarely present as a high grade pleomorphic malignant 
soft tissue tumour and needs to be distinguished from soft tissue sarcomas and metastatic carcinomas that express 
epithelial antigens.
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Background
Meningiomas are relatively common primary intracra-
nial tumours that arise within the leptomeninges or dura 
mater; these tumours exhibit morphological and immu-
nophenotypic evidence of origin from meningothelial 
cells which are present in the arachnoid membrane and 
arachnoid villi associated with the intradural venous 
sinuses and their tributaries [1]. The majority of menin-
giomas arise within the cranial cavity and are supraten-
torial dura-based lesions that develop most commonly 
in the vicinity of the superior sagittal sinus, over the 
cerebral convexities or in contact with the falx cerebri. 
Approximately 12% arise in the spine.
Meningiomas show considerable morphologic varia-
tion and are most commonly benign tumours (Grade I) 
[2, 3]. Atypical (Grade II) and anaplastic (Grade III) men-
ingiomas, which have aggressive/malignant potential, 
are distinguished on the basis of mitotic activity and a 
number of other features (e.g. pleomorphism, cellularity, 
necrosis). Anaplastic meningiomas commonly recur and 
very rarely have been known to metastasise to extrac-
ranial tissues and organs [3–5]. The true prevalence of 
metastatic malignant meningioma is unknown as many 
reported cases and case series include cases of “benign 
metastasising meningioma”, as well as tumours that were 
in the past incorrectly classified as meningiomas (e.g. 
angioblastic meningioma which is now known to be a 
solitary fibrous tumour).
The most frequently reported sites of extracranial 
metastasis of malignant meningioma are lung, spine and 
liver [3–13]. There are very few reports of malignant 
meningioma metastasising to deep soft tissues [4, 14–
16]. We report a case of a metastatic anaplastic meningi-
oma which presented as a growing soft tissue tumour in 
the trapezius muscle and review the literature regarding 
soft tissue involvement by metastatic meningioma.
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Case presentation
A 55 year old man was admitted to hospital with a head 
injury that resulted in hearing loss on the left side with 
pulsatile tinnitus and a vague feeling of disorientation. A 
CT scan showed an irregular extra-axial solitary lesion 
lying adjacent to the falx on the right of the midline 
measuring 3 × 4 × 6 cm with significant mass-effect and 
peritumoral oedema involving most of the right frontal 
lobe. There was evidence of underlying bone remodelling 
with vascular dural supply and heterogeneous enhance-
ment after contrast administration with a deep cystic 
component. There were fringes of tumour interdigitat-
ing with the brain substance indicating probable brain 
invasion (Fig.  1). The findings were consistent with an 
aggressive frontal meningioma. Partial surgical removal 
of the lesion in the right frontal lobe was undertaken. 
On histological examination, the lesion was classified 
as an atypical (WHO Grade II) meningotheliomatous 
meningioma.
A year later, the patient experienced an episode of sei-
zures and a CT scan revealed three new lesions at the 
site of the previously excised meningioma with extensive 
perilesional oedema. An MRI confirmed the CT find-
ings indicative of tumour and also detected invasion and 
occlusion of the anterior part of the superior sagittal sinus 
(Fig. 2). Partial resection of the recurrent mass was again 
undertaken. Histology of the tumour specimen showed 
features of an anaplastic (WHO Grade III) meningothe-
liomatous meningioma with lobules of tumour contain-
ing cells with round or oval vesicular nuclei. Focally, 
there were cells which showed more prominent nuclear 
pleomorphism. There was increased mitotic activity and 
extensive tumour necrosis was noted (Fig. 3). Post-oper-
ative follow-up revealed residual tumour in the anterior 
part of the superior sagittal sinus, along the falx and the 
right frontal convexity. Follow-up imaging also confirmed 
interval progression of the residual meningioma.
The patient completed a course of radiotherapy and, 
nine months later, a mobile soft tissue lump on his 
back was noted. A thoracic CT scan revealed a soft tis-
sue lesion superficially located in the inferior portion of 
the left trapezius muscle. The lesion was lobulated, had 
a low attenuation centre, showed peripheral enhance-
ment and did not exhibit evidence of matrix calcification 
(Fig.  4). The lesion increased in size and a subsequent 
MRI scan performed 6 months later confirmed the pres-
ence of a solid soft tissue mass up to 5  cm in diameter 
in the medial left trapezius muscle. The lesion indented 
the underlying paravertebral muscles but remained well-
defined and did not invade the deeper musculature. The 
lesion returned isointense T1-W signal relative to skeletal 
muscle and heterogeneous high T2-W signal. There was 
no internal calcification, haemorrhage or cystic degen-
eration. Peripheral feeding vessels were present (Fig. 5). A 
PET-CT scan demonstrated that the intramuscular lesion 
was extremely FDG avid with an SUVmax of 22.1 (Fig. 6). 
PET-CT also revealed disseminated, markedly FDG avid 
metastases in liver, bone and pleura and residual menin-
gioma in the right frontal lobe.
The lesion was biopsied and showed a largely lobulated 
tumour containing collections of tumour cells, many 
of which showed similar features to those seen in the 
Fig. 1 Axial CT post contrast image (a) and sagittal reconstruction (b) shows an irregular extra-axial solid mass with heterogeneous enhancement 
and deep cystic change (arrow) adjacent to the falx extending into the right frontal lobe. There is significant peritumoral oedema and mass effect 
involving the right frontal lobe with displacement of the midline. These findings, together with tumour interdigitating with the brain substance, are 
consistent with an aggressive frontal meningioma
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frontal lobe tumour. There were a few whorled collec-
tions of tumour cells with round or oval vesicular nuclei 
(Fig.  7). There was prominent nuclear pleomorphism, a 
high mitotic rate and focal tumour necrosis. Focally there 
were solid areas of proliferation of pleomorphic tumour 
cells, some of which had vacuolated cytoplasm. Immu-
nohistochemistry showed strong expression of epithe-
lial membrane antigen (EMA) and P63; there was also 
focal expression of cytokeratin (CK7+, CK20−), nuclear 
staining for IN-1, and a high Ki-67 fraction. There was 
no expression of desmin, S100, CD10, CD30, CD68, 
myogenin, smooth muscle actin, estrogen receptor, pro-
gesterone receptor, chromogranin, carcinoembryonic 
antigen or TTF1. There was initially some difficulty in 
establishing the pathological diagnosis as the previous 
history of recurrent atypical/anaplastic meningioma was 
not provided to the reporting pathologist whose initial 
differential diagnosis included a soft tissue metastasis of 
carcinoma and a primary soft tissue sarcoma express-
ing the epithelial markers. However, once the history of 
meningioma and the radiological findings were taken 
into account, it was clear that the soft tissue mass repre-
sented a metastasis of the previously diagnosed anaplas-
tic meningotheliomatous meningioma.
A wide local excision of the lesion, which measured 
5  ×  3  ×  2  cm, was performed; this included a cuff of 
normal muscle around the lesion and a 1 cm margin of 
skin around the previous biopsy scar. Histological find-
ings in the resection specimen were similar to those of 
the biopsy. Further follow up of the patient by CT scan 
showed no recurrence of the soft tissue lesion but pro-
gression of disease in the brain.
Fig. 2 Axial CT post contrast image showing: a nodular enhancing masses and perilesional oedema in the right frontal lobe, indicative of local 
recurrence of the meningioma. b A sagittal T1-weighted MR image post contrast confirming the presence of three lesions and invasion of the 
superior sagittal sinus (arrows)
Fig. 3 Histology of the anaplastic (Grade III) meningioma of the 
frontal lobe showing; a lobules of meningotheliomatous tumour 
containing cells with round vesicular nuclei, b areas of focal tumour 
necrosis containing more pleomorphic tumour cells
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Discussion
Extracranial metastasis of meningioma occurs rarely 
with only a few case reports documenting deep soft tis-
sue as a site of metastasis [4, 14–17]; it is not clear from 
many of these reports whether, as in our case, the metas-
tasis involved soft tissue alone or whether other con-
tiguous structures, such as lymph nodes and bone, were 
also involved. Doxtader et  al. [14] described an aggres-
sive meningioma in an 8 year old patient with metasta-
sis to cervical soft tissue and lymph nodes. There is also 
a report of an isolated “chest wall” metastasis and of a 
bone/soft tissue metastasis from an atypical primary 
meningioma of the nasal septum that clinically simulated 
a soft tissue sarcoma [15, 16]. In a review of the literature 
between 1886 and 1958, Karasick et  al. [5] reported 56 
patients who developed extracranial meningioma metas-
tasis, none of which were in soft tissue. In the database 
review of Enam et  al. [9], the incidence of meningioma 
metastasis was 0.76% with no soft tissue metastasis being 
noted. Forest et al. [3] also carried out a database review 
totalling 1291 meningiomas and identified only four 
cases of metastatic meningioma, none of which was in 
soft tissues.
A recent review of the literature on all reports of dis-
tant metastasis of intracranial meningiomas found that 
in 115 patients with 164 metastatic lesions, 83.9% were 
Grade I (benign), 20.0% were Grade II (atypical) and 
40% Grade III (anaplastic) meningiomas [4]. This analy-
sis excluded pathological entities such as “angioblastic 
meningioma”, meningeal carcinomas and sarcomas, all 
of which were formerly considered to represent subtypes 
of meningioma. In this review, 6% of cases developed in 
cervical soft tissue, 2.4% in skin and subcutaneous tis-
sue and 1.8% in muscle. Haematogenous spread of men-
ingiomas through the paravertebral and jugular venous 
systems, which also drain thoracic tissues, has been 
postulated and could account for the relatively high fre-
quency of the neck and upper trunk as a site of soft tis-
sue and lymph node metastasis. Although anaplastic 
and atypical meningiomas were most commonly associ-
ated with metastatic lesions, comprising 31.3 and 19.1% 
of cases respectively, it was noted that Grade I meningi-
omas can also give rise to metastatic lesions. It was also 
noted that in 93% of cases the intracranial meningioma 
was diagnosed and resected before the distant metasta-
sis appeared. The prognosis of intracranial meningioma 
is determined by the histological grade [1, 2], and in our 
case progression of the intracranial tumour to a higher 
histological grade was noted.
Radiological features of the chest wall tumour in our 
case were not specific; the diagnosis of a metastatic 
tumour was supported radiologically by the interval 
increase in the size of the lesion, as well as high FDG 
uptake and the finding of lesions at other sites on the PET-
CT scan. Multiple deposits were also observed in other 
extracranial sites in previous reports of soft tissue metas-
tasis from malignant meningioma [3, 4]. The tumour in 
the frontal lobe showed several radiological findings that 
have been described as potential markers of atypical or 
malignant meningiomas including indistinct or irregular 
tumour margins, marked peritumoral oedema, inhomo-
geneous enhancement post-contrast, intrinsic cyst-like 
areas, disruption of the arachnoid at the brain-tumour 
interface and adjacent bone destruction [18–24].
Fig. 4 Axial thorax CT post contrast image showing an ill-defined soft tissue mass (arrow) superficially located in the left trapezius muscle with 
peripheral enhancement and low signal in the centre
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Fig. 6 PET-CT confirms the presence of an FDG avid soft tissue mass in the left trapezius muscle
Fig. 5 Sagittal T2 (a), axial T1 (b) and axial T2 fat saturated (c) MR images demonstrate a solid well defined soft tissue mass in the medial left trape-
zius muscle which returns isointense T1-W (between arrow heads) and heterogeneous predominantly high T2-W signal relative to skeletal muscle. 
There is mass effect on the deeper paravertebral muscles and peripheral feeding vessels along the lateral aspect of the lesion (arrow)
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Histological features of the chest wall tumour showed 
that it was focally necrotic and contained collections 
of tumour cells with elongated cytoplasm and round 
or oval vesicular nuclei; there was prominent nuclear 
pleomorphism and increased mitotic activity. Morpholog-
ically, the differential diagnosis was wide and included sar-
coma, lymphoma, metastatic melanoma and carcinoma. 
Immunohistochemistry showed expression of epithelial 
markers on tumour cells with diffuse, strong staining for 
EMA and focal staining for cytokeratin. In the absence of 
any previous history, and taking into account other immu-
nohistochemical findings, these features were thought to 
favour metastatic carcinoma or a sarcoma expressing epi-
thelial markers. Several sarcomas are known to express 
epithelial markers, including synovial sarcoma, epithelioid 
sarcoma, epithelioid malignant peripheral nerve sheath 
tumour, myoepithelioma and leiomyosarcoma [25] Mor-
phological and immunophenotypic features were not 
typical of any of these specific tumour types. Soft tissue 
metastasis of carcinoma is well recognised with autopsy 
series reporting that this occurs in 0.75–9% of patients 
who die of metastatic carcinoma [26–29]. Lung is the most 
common primary carcinoma that results in soft tissue 
metastasis with a mean prevalence of 2.3% being reported 
[30], and the cytokeratin profile in our case was consist-
ent with a metastatic lung carcinoma; it was not typical 
for metastatic renal or colon carcinoma, both which have 
also been reported to produce soft tissue metastasis with 
relative frequency. Although metastatic malignant menin-
gioma is much less common than metastatic carcinoma, 
the prevalence of metastatic meningioma in skin, subcu-
taneous tissue and muscle is, at least in one case series [4], 
comparable to that of metastatic carcinoma. In our case 
the diagnosis of metastatic meningioma became clear 
when the full past history of the patient was recognised. 
It could be argued that the possibility of malignant men-
ingioma should have been suspected earlier given that the 
morphological and immunohistochemical findings were 
so typical of this tumour with focal, occasionally whorled 
collections of strongly EMA+ tumour cells being typical 
of a meningotheliomatous meningioma [1, 2]. It should be 
noted that in more diagnostically challenging cases cer-
tain genetic/cytogenetic abnormalities such as inactivating 
mutations of NF2, monosomy 22, as well as specific altera-
tions in gene expression, may also be useful in establishing 
the diagnosis of metastatic meningioma [31].
Conclusion
Knowledge of the clinical and radiological information 
was essential to establish the diagnosis of metastatic 
malignant meningioma in our case, particularly the pre-
vious history of anaplastic meningioma and the radio-
logical identification of FDG avid lesions at several sites. 
Although very rare, the possibility of metastatic menin-
gioma should be considered in the differential diagnosis 
of a malignant soft tissue tumour, where tumour cells 
strongly express EMA and other epithelial markers.
Fig. 7 Histology of the metastatic meningioma in soft tissues show-
ing: a lobules of tumour showing features of meningotheliomatous 
meningioma similar to the primary brain tumour b areas where 
tumour cells exhibit marked nuclear pleomorphism and contain 
prominent nucleoli. c Expression of EMA by tumour cells
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